GS-441524 based antivirals remain the centrepiece of FIP treatment. Broad-spectrum CBD does not replace them. It is drawing attention as a supplementary product that may support a cat's quality of life through the 84 days of treatment and can be continued afterwards as part of everyday wellness care.
This page separates what research in cats does show from what it does not, so you can weigh the option safely.
CBD does not cure FIP. The core of FIP treatment must always be a GS-441524 based antiviral. Never reduce the antiviral dose or interrupt dosing because your cat is receiving CBD. With that firmly established, this page looks at the supportive role CBD may play.
CBD (cannabidiol) is one of the compounds found in hemp. The word "hemp" may bring illegal drugs to mind, but intoxication comes from THC, an entirely different compound. CBD on its own produces no "high" or intoxicating effect. In its 2018 review, the World Health Organization concluded that CBD alone shows no potential for abuse or dependence.
Cats, like humans, are born with a regulatory network called the endocannabinoid system (ECS). It helps keep pain perception, mood, sleep, immunity and inflammation in balance, and CBD is thought to act on this system indirectly.
The legal status of CBD differs substantially between countries, and in some cases between states or provinces within the same country. Many jurisdictions have moved from regulating the part of the plant used to regulating THC content itself, but the permitted thresholds vary — and in some places CBD products remain restricted or prohibited altogether.
Before purchasing or importing, please check the rules that apply where you live. Whatever your jurisdiction, choosing a product whose THC content can be verified on a third-party certificate of analysis (COA) is essential for both legal and safety reasons.
CBD products fall into three types according to the range of compounds they contain. Cats are highly sensitive to THC and have limited enzyme capacity for metabolising certain plant compounds such as terpenes, so what is in a product — and what is not matters even more than it does for dogs or humans.
| Type | Compounds included | THC | Entourage effect (hypothesis) | Suitability for cats |
|---|---|---|---|---|
| Full-SpectrumFull-Spectrum | Nearly all hemp compounds (CBD + other cannabinoids + terpenes) | Trace amounts present | Expected | ✕ Not recommended for cats Avoid given THC sensitivity |
| Broad-SpectrumBroad-Spectrum ★ | All but THC (CBD + other cannabinoids + terpenes) | Non-detectable (ND) | Partly expected | ◎ First choice Choose a product formulated for cats |
| IsolateIsolate | CBD only (all other compounds removed) | None | None | ○ The safety-first option Sensible for cats prone to sensitivity |
* "Non-detect (ND)" means below the detection limit of the analytical instrument; it is not a guarantee of absolute zero. This is precisely why it matters to choose a product whose measured values can be checked on a COA.
Cats are sensitive to THC, and in many jurisdictions THC-containing products are restricted as well. That rules out full-spectrum. At the same time, there is a hypothesis known as the entourage effect — the idea that non-THC cannabinoids (CBG, CBC and others) and terpenes enhance the action of CBD when they work together. Broad-spectrum is the type that keeps that possibility open.
To be candid, however, the entourage effect remains a hypothesis and has not been verified in cats. Avoiding THC while leaving the possibility open — that is the reasoning behind treating broad-spectrum as the first choice.
Cats have limited capacity for glucuronidation, the enzyme pathway that metabolises certain plant compounds, which makes them more sensitive to terpenes and essential-oil constituents. Broad-spectrum products do contain terpenes, so choose one whose terpene content has been adjusted for cats, and discontinue if your cat appears not to tolerate it.
For this reason, some veterinarians recommend isolate, which contains no terpenes at all. That is an entirely reasonable choice. If you are unsure, decide together with your own veterinarian.
The most important thing when giving CBD to a cat is not to confuse hope with confirmed fact. Rather than listing only the encouraging findings, we set out the state of the research as it actually is.
Several studies in healthy cats report that appropriate doses of CBD are generally well tolerated, from short-term use up to 26 weeks. The main adverse effects — drooling, head shaking, mild drowsiness and vomiting — were largely mild and transient.
That said, some studies reported elevated liver enzymes (ALT) in a small number of cats, so monitoring with periodic blood work is advised.
A 2025 double-blind, placebo-controlled trial in 26 cats with osteoarthritis (OA) reported a significant improvement in pain scores with a CBD/CBDA paste. It is the first randomised controlled trial to demonstrate an effect in cats.
At the same time, 12 of the 26 cats withdrew because of vomiting or palatability problems. The result shows both the potential benefit and the practical difficulty of getting a cat to take it — and deserves to be read honestly on both counts.
No study has yet examined whether CBD is effective in cats with FIP. The hopes described below regarding inflammation, neurological signs and stress are inferences drawn from research in humans, dogs and the laboratory — none of them has been confirmed in cats with FIP.
With that stated plainly, the next chapter looks at the areas where CBD is hoped to help as supportive care, together with the source of the evidence in each case.
Eighty-four days of treatment place a considerable burden on a cat, physically and emotionally. The label on each card indicates where the evidence comes from. Anything not marked as research in cats is an inference from other species or from laboratory work — please read it with that in mind.
Neurological FIP can bring seizures, unsteadiness and paralysis. Interest in CBD in this area stems from two facts: a CBD medicine is approved in the United States and elsewhere for treatment-resistant epilepsy in humans, and a placebo-controlled trial in dogs reported a reduction in seizure frequency when CBD was added to antiepileptic therapy (though findings are not uniform across studies).
To repeat, however, there are no data testing CBD in feline neurological FIP. We are not at a stage where any neuroprotective or seizure-reducing effect can be promised for cats. It remains one supportive option that may be considered in consultation with your veterinarian.
FIP is fundamentally an excessive immune and inflammatory response triggered by a virus. Laboratory research indicates that CBD acts through CB2 receptors on immune cells, among other pathways, to moderate excessive inflammation, and clinical reports in dogs describe effects on dermatitis and joint inflammation.
* There are no direct data showing that CBD suppresses FIP-related inflammation (effusion or granulomas). Controlling that inflammation is the job of the antiviral and your veterinarian's treatment.
Daily injections, bodily pain, internal discomfort — a cat in treatment carries a great deal. Multiple reports in canine osteoarthritis describe improved pain scores, and the 2025 placebo-controlled trial in cats also showed improvement in OA pain.
Discomfort during FIP treatment itself has not been studied, but pain care is the area where the evidence for CBD is accumulating most steadily.
Clinic visits, daily dosing, feeling unwell — stress during treatment affects a cat's appetite and immune function too. Laboratory research suggests CBD may ease anxiety through action at serotonin (5-HT1A) receptors, raising hopes for a calming effect without heavy sedation.
* Clinical evidence for anxiety in cats is still developing. Both the effect and any drowsiness vary between individuals.
CBD is sometimes promoted as something that boosts appetite, but there is no evidence that CBD itself directly increases appetite. If anything, reduced appetite is a well-known adverse effect of CBD medicines in humans, and vomiting and inappetence were the main reasons cats withdrew from clinical trials.
Eating may become steadier as a consequence of reduced pain or anxiety, but we do not recommend using CBD with the goal of stimulating appetite. If inappetence persists, there are established appetite stimulants your veterinarian can prescribe — please ask.
"Is it safe to give alongside the medication?" is the question we hear most. The short answer is that no data directly examine this combination, so consulting your veterinarian is the starting point. Below are the facts that can inform that conversation.
No study in cats or any other species has examined the interaction between GS-441524 and CBD. "No problems reported" is not the same as "confirmed safe." Please make your decision with that uncertainty in mind.
GS-441524 is reported to be excreted mainly by the kidneys (in urine) and depends little on hepatic drug-metabolising enzymes (CYP450). Because CBD can inhibit CYP450, there is potential for interference in cats also receiving drugs that rely on hepatic metabolism, such as corticosteroids or antiepileptics. With GS-441524 alone, however, the theoretical risk appears limited.
Studies of CBD in cats have reported elevated liver enzymes (ALT) in some individuals. Regular blood work is standard during FIP treatment, so tell your veterinarian that your cat is receiving CBD and ask them to review liver values at the same time. If anything looks abnormal, stopping CBD is perfectly reasonable.
Avoid starting the antiviral and CBD at the same time, while your cat's condition is still unstable in the early days of treatment. Begin with a small amount only once treatment is established and your cat is stable, and record the start date, the amount and how your cat responds. That way, if something changes, you can tell what caused it.
Never reduce or stop the antiviral because your cat seems to be doing well on CBD. Interrupting or reducing treatment translates directly into relapse risk. CBD belongs alongside treatment, never in place of it.
Even after 84 days of dosing ends, an observation period of roughly 12 weeks follows. CBD's role here is the same: quality-of-life support, not treatment. There are no data showing that CBD prevents disease — with that understood, here are the situations where it may help.
Check-ups and clinic visits continue after dosing finishes. For cats who tense up at every examination, or who are sensitive to changes around them, CBD may be worth considering as one way to help them stay settled.
Stiff joints and chronic discomfort erode quality of life in older cats. Given the clinical trial showing improvement in feline OA pain, this is an area of active research as an option for keeping senior cats comfortable.
Moving house, visitors, clinic trips, thunder or fireworks — some owners consider CBD for these temporary spikes in stress. Responses vary between cats, so try it during a calm period first to see whether it suits yours.
Once the 84 days of treatment and the observation period are behind you, there is no need to think of CBD as finished. A habit begun for treatment can simply carry on as a supplement supporting everyday health. That is the suggestion at the heart of this page. The purpose, however, is not relapse prevention — and that distinction matters, as set out below.
Even after remission, check-ups and blood draws keep coming. Keeping the familiar "oil time" that became established during treatment is a kind choice, in the sense that it preserves the rhythm of daily life. The daily dosing itself also becomes a moment to observe your cat closely.
A long-term study reported in 2024 found that healthy cats tolerated 4 mg of CBD per kg of body weight daily for 26 weeks (about six months). These are data pointing towards continued use as a daily supplement, rather than a short trial.
* This was a study in healthy cats. It has not been tested in cats following FIP remission.
A cat who has come through FIP will still, with age, face stiff joints and other chronic discomfort. With a 2025 clinical trial reporting improvement in feline osteoarthritis pain, this is an area where continuing has value with the senior years in view.
Precisely because this is long-term use, have blood work including liver enzymes (ALT) done regularly. Tell your veterinarian each time that your cat is receiving CBD.
Body weight shifts with growth and age. When it does, adjust the amount according to the product label and your veterinarian's guidance.
CBD is not habit-forming (WHO, 2018). Interrupting it for travel or illness carries no risk of withdrawal, and when you resume, starting small is enough.
Rather than continuing out of habit, look back over your notes on appetite, activity and sleep, and keep checking that it genuinely suits your cat.
No data show that continuing CBD prevents FIP relapse. What catches relapse early is regular check-ups and daily observation. Continue it as quality-of-life support only — and if you notice changes such as lethargy or reduced appetite, do not wait and watch with CBD. Contact your veterinarian straight away.
Quality varies enormously across the CBD market. Because this is something you will give to a cat, choose a product that meets all five of the following.
A per-batch certificate should let you verify results for CBD content, THC content, pesticides, heavy metals and residual solvents. This is the baseline. Do not buy from a manufacturer that cannot produce a COA.
Look past marketing claims of "THC-free" and confirm the measured value as ND (below the detection limit) on the COA. Meeting your jurisdiction's legal threshold is the minimum; for cats, ND is the standard to hold to.
Do not use products made for humans. They may contain ingredients harmful to cats, including xylitol, essential oils, flavourings and sweeteners. Choose a product designed around feline metabolism.
A simple composition — a carrier oil such as MCT plus the CBD extract — is ideal. If you choose broad-spectrum, check that the terpene content has been kept low for cats.
Cats are small, so being able to fine-tune the amount matters. Look beyond total content per bottle for the CBD amount per drop or per graduation, and start with a low- to mid-strength product. Concentrated products make dosing errors easy — avoid them until you are comfortable.
The rule is start low, go slow, keep notes. Studies in cats have generally used somewhere in the range of 1–4 mg per kg of body weight per day, but concentrations differ by product. Always defer to the product label and your veterinarian's instructions.
Begin at the lower end of the label range, or half of it. Observe over one to two weeks and adjust gradually if needed. The right amount differs for every cat.
Dropped directly into the mouth (inside the cheek) it is absorbed faster; mixed into food it acts more gently. Plenty of cats dislike it. Forcing the issue is counterproductive — it simply becomes another source of stress.
Note appetite, activity, sleep and anything that concerns you. This is not a fast-acting medication, so do not rush to judgement — review your notes together with your veterinarian.
If marked drowsiness, unsteadiness, vomiting, diarrhoea, reduced appetite or persistent drooling appear, stop and consult your veterinarian. There is no reason to persist with a cat it does not suit.
The 84 days of fighting FIP are a long road, for the cat and for you.
We hope you will consider CBD with accurate knowledge —
as one option for making that road a little gentler,
and as a habit that stays with your cat after remission.
Whenever you are uncertain or worried, please get in touch.
* Always consult your own veterinarian before using any CBD product.
The information on this page is not a substitute for medical care or diagnosis.